Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Scott Chin currently holds 204,538 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Peter Scott Chin has been a net seller of DNLI stock. They have purchased $0 and sold $36.9K worth of shares.
Peter Scott Chin's most recent insider trade was on Sep 4, 2026, when they sold 1,654 shares at $22.29 per share.
Peter Scott Chin serves as Chief Medical Officer at Denali Therapeutics Inc. (DNLI). They have executed 1 insider transactions totaling $36.9K over their tenure at the company.
Peter Scott Chin holds the position of Chief Medical Officer at Denali Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Peter Scott Chin has shown a selling trading pattern, with $0 in total purchases and $36.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter Scott Chin was on Sep 4, 2026, when they sold $36.9K worth of DNLI shares. This transaction involved 1,654 shares at $22.29 per share.
Peter Scott Chin currently owns 204,538 shares of Denali Therapeutics Inc. (DNLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Scott Chin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Scott Chin has 1 Form 4 filings on record as an insider at Denali Therapeutics Inc..
Set alerts for Peter Scott Chin and 40,000+ other insiders.